Lanzillo R - Search Results

1

The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis.

Monteiro I, Nicolella V, Fiorenza M, Novarella F, Carotenuto A, Lanzillo R, Mauriello L, Scalia G, Castaldo G, Terracciano D, Brescia Morra V, Moccia M. Monteiro I, et al. Among authors: lanzillo r. J Neurol. 2024 May 23. doi: 10.1007/s00415-024-12434-w. Online ahead of print. J Neurol. 2024. PMID: 38777960

2

Integration of the expanded disability status scale with ambulation, visual and cognitive tests.

Sarnataro A, Cuomo N, Russo CV, Carotenuto A, Lanzillo R, Moccia M, Petracca M, Morra VB, Saccà F. Sarnataro A, et al. Among authors: lanzillo r. Neurol Sci. 2024 Apr 30. doi: 10.1007/s10072-024-07559-9. Online ahead of print. Neurol Sci. 2024. PMID: 38689096

3

Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study.

Moccia M, Affinito G, Marrazzo G, Ciarambino T, Di Procolo P, Confalonieri L, Carotenuto A, Petracca M, Lanzillo R, Triassi M, Brescia Morra V, Palladino R. Moccia M, et al. Among authors: lanzillo r. Neurol Int. 2024 Mar 29;16(2):394-405. doi: 10.3390/neurolint16020029. Neurol Int. 2024. PMID: 38668126 Free PMC article.

4

Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications.

Spiezia AL, Scalia G, Petracca M, Caliendo D, Moccia M, Fiore A, Cerbone V, Lanzillo R, Brescia Morra V, Carotenuto A. Spiezia AL, et al. Among authors: lanzillo r. J Neurol. 2024 Apr 17. doi: 10.1007/s00415-024-12362-9. Online ahead of print. J Neurol. 2024. PMID: 38632126

5

ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.

Maida E, Moccia M, Palladino R, Borriello G, Affinito G, Clerico M, Repice AM, Di Sapio A, Iodice R, Spiezia AL, Sparaco M, Miele G, Bile F, Scandurra C, Ferraro D, Stromillo ML, Docimo R, De Martino A, Mancinelli L, Abbadessa G, Smolik K, Lorusso L, Leone M, Leveraro E, Lauro F, Trojsi F, Streito LM, Gabriele F, Marinelli F, Ianniello A, De Santis F, Foschi M, De Stefano N, Morra VB, Bisecco A, Coghe G, Cocco E, Romoli M, Corea F, Leocani L, Frau J, Sacco S, Inglese M, Carotenuto A, Lanzillo R, Padovani A, Triassi M, Bonavita S, Lavorgna L; Digital Technologies, Web, Social Media Study Group of the Italian Society of Neurology (SIN). Maida E, et al. Among authors: lanzillo r. J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12328-x. Online ahead of print. J Neurol. 2024. PMID: 38568227

6

Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.

Signoriello E, Foschi M, Lanzillo R, Frau J, Cocco E, Borriello G, Ianniello A, Trotta M, Landi D, Maniscalco GT, Ruscica F, Toscano S, Patti F, Zanghì A, D'Amico E, Fantozzi R, Centonze D, Lus G, Bonavita S. Signoriello E, et al. Among authors: lanzillo r. J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12291-7. Online ahead of print. J Neurol. 2024. PMID: 38568225

7

Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

Moccia M, Santoni L, Vaccari I, Affinito G, Caliendo D, Rubba F, Lanzillo R, Triassi M, Brescia Morra V, Palladino R. Moccia M, et al. Among authors: lanzillo r. Eur Rev Med Pharmacol Sci. 2024 Feb;28(4):1241. doi: 10.26355/eurrev_202402_35445. Eur Rev Med Pharmacol Sci. 2024. PMID: 38436157 Free article.

8

The impact of image contrast, resolution and reader expertise on black hole identification in Multiple Sclerosis.

Tranfa M, Scaravilli A, Pastore C, Montella A, Lanzillo R, Kimura M, Jasperse B, Morra VB, Petracca M, Pontillo G, Brunetti A, Cocozza S. Tranfa M, et al. Among authors: lanzillo r. Neuroradiology. 2024 Feb 19. doi: 10.1007/s00234-024-03310-5. Online ahead of print. Neuroradiology. 2024. PMID: 38374410

9

Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.

Moccia M, Santoni L, Vaccari I, Affinito G, Caliendo D, Rubba F, Lanzillo R, Triassi M, Brescia Morra V, Palladino R. Moccia M, et al. Among authors: lanzillo r. Eur Rev Med Pharmacol Sci. 2024 Jan;28(1):411-418. doi: 10.26355/eurrev_202401_34930. Eur Rev Med Pharmacol Sci. 2024. PMID: 38235893 Free article.

10

Switching to ozanimod as a strategy to adjust fingolimod-related lymphopenia.

Caliendo D, Grassia MC, Carotenuto A, Petracca M, Lanzillo R, Brescia Morra V, Moccia M. Caliendo D, et al. Among authors: lanzillo r. Mult Scler Relat Disord. 2024 Jan;81:105135. doi: 10.1016/j.msard.2023.105135. Epub 2023 Nov 11. Mult Scler Relat Disord. 2024. PMID: 38006850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page